YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Class Action Lawsuits Filed Against the Makers of the Diabetes Drugs Januvia, Byetta, Janument and Victoza Claiming They Cause Serious Side Effects Such as Pancreatitis and Pancreatic Cancer

According to class action lawsuits filed nationwide against Merck, Amylin, Eli Lilly, Bristol-Myers Squibb and Novo Nordisk A/S, the makers of the diabetes drugs Januvia, Byetta, Janument and Victoza, the companies marketed these medicines as safe knowing they were dangerous and failed to warn the public of the increased risks of pancreatic cancer and pancreatitis.

If you or a family member has taken Januvia, Byetta, Janumet and/or Victoza and have been injured, you may be entitled to compensation.

• Our firm is vigorously pursuing this matter.
• Our clients have received millions of dollars in lawsuits involving defective drugs.
• No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About Januvia, Janument, Byetta and Victoza

Januvia, Byetta, Janumet and Victoza are prescription drugs used to treat Type 2 diabetes. Merek is the maker of Januvia and Janument. Byetta is manufactured Amylin, Eli Lilly and Bristol-Myers Squibb. Victoza is manufactured by Novo Nordisk A/S. The FDA approved the use of Byetta, Januvia, Janument and Victoza in 2005, 2006, 2007 and 2010, respectively. All of these drugs are classified as incretin mimetics. The FDA has issued warnings stating these drugs can cause serious medical problems such as pancreatic diseases.

Plaintiffs in class action lawsuits filed nationwide against the makers of these drugs have claimed they developed pancreatitis and pancreatic cancer due to the use of the drugs. Plaintiffs also allege the drugmakers knew or should have known about the dangerous side effects, failed to test the drugs adequately and monitor the side effects and failed to warn the public of the increased risks of developing pancreatic diseases and cancer.